ABO subgroups Flashcards

1
Q

ABO subgroups represent:

A

Phenotypes showing weaker and variable serologic reactivity with anti-A, anti-B, and anti-A,B reagents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cause of ABO subgroups:

A

Result of less effective enzymes that convert H antigens to A or B antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Key difference in ABO subgroups:

A

Amount of antigen present on the red blood cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phenotype A1: Antigens present and population frequency

A

Antigens: A, A1; Frequency: 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phenotype A2: Antigens present and population frequency

A

Antigens: A; Frequency: 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reactivity of A1 individuals with anti-A (B sera) and anti-A1 lectin

A

Positive for both anti-A and anti-A1 lectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Reactivity of A2 individuals with anti-A (B sera)

A

Positive for anti-A only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Frequency of anti-A1 formation in A2 individuals

A

1-8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Frequency of anti-A1 formation in A2B individuals

A

0.25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anti-H lectin reactivity comparison: A1 vs A2 RBCs

A

A2 shows increased reactivity with anti-H lectin compared to A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Weak A subgroup characteristics: Antigen sites per RBC

A

Decreased number of A antigen sites per RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Weak A subgroup characteristics: Agglutination with human anti-A, B

A

Variable degrees of agglutination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Weak A subgroup characteristics: Detectability of H antigen

A

Strong reactions with anti-H due to variability in detectability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Weak A subgroup characterization methods

A

Secretor studies, adsorption studies, and molecular testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Subgroups of A showing mixed-field reactions

A

A3, Ax, Aend

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Subgroups of A with no reaction with anti-A and anti-AB

A

Am, Ay, Ael

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Subgroup of B with mixed-field agglutination with anti-B and/or anti-A,B

A

B3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Subgroup of B with agglutination only with anti-A,B (weak/none with anti-B)

A

Bx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Subgroup of B with no agglutination with anti-B and anti-A,B

A

Bm, Bel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Subgroup of B with secretors demonstrating quantities of B substance in saliva

A

Bel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Subgroup of B with secretors containing only H substance and no B substance in saliva

A

Bel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Year and location of first reported H-deficient case (Bombay phenotype)

A

1952, Bombay, India

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Phenotype lacking ABH antigen expression, typing as hh antigen

A

Bombay phenotype

24
Q

Consequence of no H antigens being formed in Bombay phenotype

A

No A nor B antigens are formed; phenotypes as blood group O

25
Serum composition in Bombay phenotype
Anti-A, anti-B, anti-AB, and anti-H
26
Blood compatibility for transfusion in Bombay phenotype
Only from another Bombay (Oh)
27
Genotype of classic Bombay phenotype
hh/sese
28
Genotype of para Bombay phenotype
hh/Se
29
Genotype of H-partially deficient variant
hh/se
30
Glycosyltransferase activity in para Bombay phenotype
A and/or B transferase
31
Glycosyltransferase activity in H-partially deficient variant
A and/or B transferase
32
Antibodies present in classic Bombay phenotype
Anti-A, Anti-B, Anti-H
33
Antibodies present in para Bombay phenotype
Weak Anti-H, Anti-A/B
34
Antibodies present in H-partially deficient variant
Anti-H, Anti-A/B
35
**Source of group-specific substances (Ernest Witebsky) for A and B antigens**
A: Hog stomach B: Horse stomach
36
Common ABO discrepancy involving defects in reverse typing
Group I: Missing or weakly reacting antibodies | may be due to age, medications, and other health conditions
37
ABO discrepancy detected in **forward typing** due to missing or weakly reacting antigens
Group II
38
ABO discrepancy detected in both forward and reverse typing due to protein or plasma abnormalities
Group III
39
ABO discrepancy in reverse typing caused by miscellaneous issues
Group IV
40
Group II discrepancy due to weakened antigens neutralized by blood group-specific soluble substances (BGSS)
Subgroups of A(B), leukemias, acquired B phenomenon
41
Reaction seen in acquired B phenomenon with Anti-B clone ES4
Positive reaction
42
Reagent treatment to re-acetylate surface molecules and reduce anti-B reactivity in acquired B phenomenon
Acetic anhydride treatment
43
Anti-B pH range for reduced reactivity in acquired B phenomenon
pH >8.5 or <6.0
44
Substance used to neutralize anti-sera in acquired B phenomenon
Blood group-specific soluble substance (BGSS)
45
Group I discrepancies are common in these populations or conditions
Newborns, elderly patients, hypogammaglobulinemia, agammaglobulinemia, patients receiving plasma transfusion or exchange transfusion
46
Rare Group I discrepancy caused by two cell populations in one individual
Chimerism
47
Group II discrepancies can occur due to these conditions
Leukemia, Hodgkin's disease, A/B subgroups, acquired B phenomenon, antibodies to low-incidence antigens
48
Group III discrepancy is caused by these conditions
Elevated globulin levels (e.g., multiple myeloma, Waldenstrom’s macroglobulinemia, advanced Hodgkin's lymphoma), elevated fibrinogen, plasma expanders (dextran, polyvinylpyrrolidone), Wharton’s jelly in cord blood
49
ABO discrepancy seen with elevated levels of fibrinogen or plasma expanders
Group III
50
Group IV discrepancy causes
Cold reactive autoantibodies, more than one ABO group due to RBC transfusion or bone marrow transplant (BMT), unexpected alloantibodies, unexpected ABO isoagglutinins
51
Group IV discrepancy involving inherited genetic variation of the ABO group
Cis-AB
52
Definition of Cis-AB
Inheritance of both A and B genes from one parent on the same chromosome, with an O gene inherited from the other parent
53
Group III discrepancy commonly seen in this type of blood sample
Cord blood contaminated with Wharton’s jelly
54
Cold reactive autoantibodies causing ABO discrepancies are categorized as
Group IV
55
Discrepancy in a patient with both RBC transfusion and bone marrow transplant presenting multiple ABO groups
Group IV
56
Unexpected ABO isoagglutinins are a feature of which discrepancy group
Group IV